Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics

The COVID-19 crisis, incited by the zoonotic SARS-CoV-2 virus, has quickly escalated into a catastrophic public health issue and a grave threat to humankind owing to the advent of mutant viruses. Multiple pharmaceutical therapies or biologics envision stopping the virus from spreading further; howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Panda, Mamta, Kalita, Elora, Singh, Satyendra, Kumar, Ketan, Prajapati, Vijay Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676808/
https://www.ncbi.nlm.nih.gov/pubmed/36400898
http://dx.doi.org/10.1007/s11030-022-10570-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676808/
https://www.ncbi.nlm.nih.gov/pubmed/36400898
http://dx.doi.org/10.1007/s11030-022-10570-x

Ejemplares similares